Skip to content
Search AI Powered

Latest Stories

Johnson & Johnson is the world’s most innovative pharmaceutical company

Johnson & Johnson is the world’s most innovative pharmaceutical company

Johnson & Johnson spent £37.1 billion on intangible assets and £11.87 billion on R&D last year

Johnson & Johnson has made it to the list of top 10 most innovative companies in the world released by FOREX.com.


The US-based pharmaceutical company is the fourth most innovative company, scoring 8.23/10 in the innovation index.

Johnson & Johnson is the only pharmaceutical company making it to top 10 list, which makes it the world’s most innovative pharmaceutical company in 2023.

The ranking is based on many factors such as the number of US-registered patents in 2022, the number of R&D expenses over the last 12 consecutive months and their last reported intangible assets.

The health giant spent £37.16 billion on intangible assets (the second highest after Apple), £11.87 billion on R&D last year and registered 1,377 patents last year.

Consumer electronic companies dominated the list, securing the top three spots.

Samsung tops the list with an innovation score of 9.25/10 and the highest number of new patents in 2022 (8,513).

Matthew Weller, Head of Global Market Commentary at FOREX.com, said: “The report's findings underscore Samsung's dominance in the innovation arena, with its leading number of patents reflecting a significant push in consumer electronics. This patent portfolio is not just a measure of quantity but a marker of Samsung's potential to disrupt markets and set new industry standards.”

Despite having spent the most on intangible assets out of all companies, Apple slipped to second position in the list, scoring 9.03/10.

IT giant IBM is in the third place with a score of 8.33/10 and the second highest number of new patents registered in 2022 (4743).

Intel invested 31.6 per cent (£13.6 billion) of their £43 billion revenue - the most out of all companies.

E-commerce giant, Amazon, has invested the most in R&D in the last year (£65 billion).

Experts at FOREX.com have prepared the list by analysing data from Harrity and Seeking Alpha to uncover which companies are the most innovative.

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
It is official: Opella is now a standalone company

Opella launches as an independent company to redefine the future of self-care.

Photo credit: gettyimages

Opella becomes standalone company as Sanofi-CD&R deal closes

Opella has officially become a standalone company, following the completion of Sanofi’s sale of a controlling 50.0% stake to private equity firm Clayton, Dubilier & Rice (CD&R).

Sanofi retains a significant shareholding with a 48.2% stake while Bpifrance holds the remaining 1.8% stake.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less